Clinical trials are a key research tool for advancing medical knowledge and patient care.
A clinical trial involves research using human volunteers (also called participants) that is intended to add to our medical knowledge. In a clinical trial participants receive specific interventions or treatment according to the research plan or protocol. This sets out in detail the process and design of the study, the treatment(s) to be used and the measurements that will be required.
All parties (investigators, study co-ordinators and pharmaceutical company employees) involved with the development and testing of the study medicine must follow the study protocol.
The people who volunteer to be studied during these trials are advised beforehand of possible risks.
If you have any questions about our clinical trials, please contact us on clinicaltrials@uhhc.co.nz
Current Clinical Trials
Do you have high cholesterol?
This clinical research study is testing an investigational medication in adults to learn how it works to lower cholesterol compared with a placebo. The placebo looks like the investigational medication, but contains no active ingredients. Researchers will also study how well participants tolerate taking the investigational medication and whether it reduces cardiovascular events.
You may be able to take part in this study if you are at least 18 years of age, are taking cholesterol medication with or without supplements to control your cholesterol, and have had a cardiovascular event, such as one of the following:
- heart attack
- stroke
- procedure to reopen a blocked artery in your neck or legs
- amputation due to a blocked artery
You may also be eligible if you are aged 50 or older, taking cholesterol medication with or without supplements to control your cholesterol, and are considered at high risk of a major cardiovascular event because you have health concerns, such as blockages in 2 or more arteries; or you are 60 or older and have risk factors, such as diabetes mellitus or high blood pressure.
You must continue to take your medication and/or supplements for your cholesterol while you are in this study.
There are additional requirements that must be met in order to take part in this study. The length of time you participate in the study is determined by when you join the study. The average time is about 4 and a half years.
Participants will receive the investigational medication or placebo and study-related care at no cost.
If you think this clinical research study might be a good fit, and you are interested in finding out more, including whether you are eligible, please contact us on clinicaltrials@uhhc.co.nz or ring 021 954 630.
COVID and the Flu: FIGHT THEM BOTH WITH ONE SHOT.
About the study
We are looking for adults 65 years or older to participate in a research study that seeks to assess the effectiveness of a combined COVID-19 and Flu vaccination.
To sign up or learn more, scan the QR codes to access our website: www.PCRN.co.nz
We are searching for people who:
- Are aged 65+
- Previously vaccinated against COVID-19
- In good health or with well-controlled medical conditions
About the Study:
- Attend 2-4 clinic visits and phone calls over 6 months
- You will be reimbursed for your time and travel costs
- You can leave the study at any time
Locations:
- Auckland
- New Lynn
- Rotorua
- Waikato
- Wellington
- Christchurch
- Tasman
Phone Lakeland Clinical Trials – 021 954 630 to get in touch with your nearest clinic.
Over 65’s Urinary Tract Infection Vaccine
People aged 65 years or older, with a history of urinary tract infection (UTI), are at an increased risk of developing a bloodstream infection caused by an E. coli bacteria.
A clinical research study to assess the effectiveness and safety of an investigational vaccine in the prevention of bloodstream infection is now enrolling.
You may be eligible to participate if you:
• Are 65 years of age or older
• Have had a UTI in the past 2 years
• Feel comfortable, or have a caregiver who is comfortable, using an application on a smartphone
If you are interested, additional eligibility criteria will be assessed by the study doctor or staff.
If you are found eligible to participate in this clinical research study, you will receive an investigational vaccine and complete a minimum of 8 study visits, some in person and some remote via telephone.
The commitment for the study is approximately 3 years.
Qualified participants may receive the investigational vaccine and some study-required medical care at no cost. The study will not pay for other medical care or current medication(s) needed to support your daily health care routine.
If you have any questions about our clinical trials, please contact us on clinicaltrials@uhhc.co.nz or ring 021 954 630.